Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Search results for

There are 13,022 results that match your search.13,022 results
  • New copyright legislation emphasizes China’s commitment to its international obligations. While overseas copyright owners should welcome the new law, enforcement of their rights will remain a challenge, argue Luke Minford and Stella Li
  • In Aptix Corp v Quickturn Design Systems, Inc (60 USPQ 2d 1705 (Fed Cir November 5 2001)), two members of a three-judge Federal Circuit panel held that a US patent remains "presumptively valid" and enforceable, despite the admitted blatantly fraudulent conduct of its inventor in seeking its enforcement before a federal district court. The decision is troublesome, because it overrules the contrary Federal Circuit ruling in Fraige v American National Watermattress Co (27 USPQ 2d 1149, 1151, n3 (Fed Cir 1993)) and repudiates a principle considered virtually axiomatic among US lawyers for many years ? that is, that fraud practised in connection with either acquiring or enforcing a patent renders the thus-tainted patent permanently unenforceable. Furthermore, it is difficult to see any legitimate public or private purpose that is served by pronouncing the patent presumptively valid and hence enforceable either by someone other than the original patentee or by the patentee at a later time and in the absence of the offending research notebooks.
  • Pharmacia Corp, GD Searle & Co and Pfizer Inc (the patentees) were the proprietors of European Patent (UK) 0 679 157 (the patent) relating to chemical compounds having use as non-steroidal anti-inflammatory drugs (NSAIDs). The patentees appealed the findings at trial that the patent was invalid and not infringed by the defendants, Merck & Co Inc and Merck Sharp & Dohme Ltd (Merck). On appeal, the finding of invalidity was confirmed (Court of Appeal, December 14 2001). Merck's chemical compound, sold under the name Vioxx, was held to fall within claim 1 and would have infringed if the claim had not been held invalid.
  • New copyright legislation emphasizes China’s commitment to its international obligations. While overseas copyright owners should welcome the new law, enforcement of their rights will remain a challenge, argue Luke Minford and Stella Li
  • Guylyn R Cummins, Gray Cary Ware & Freidenrich LLP
  • Ralph Cunningham, Hong Kong
  • Administrators of commercial companies in Colombia, whether national or foreign, must submit a report of performance to a general shareholders meeting. This must be done within the first three months of the fiscal year. Contained in the report must be a disclosure of the company's compliance with the provisions on IP and copyright.
  • The fair basis requirement has vanished from UK patent law – but remains an important consideration in Australia. Barry Eagar says overseas applicants must pay attention to this requirement and ensure that the claims correspond to the patent specification
  • Guylyn R Cummins, Gray Cary Ware & Freidenrich LLP
  • The directive concerning legal protection of biotechnological inventions (98/44/EC) has not been annulled according to a judgment made by the European Court of Justice (ECJ) on October 9 2001 (C 377/98).